ID: MRFR/Pharma/3389-CR | February 2021 | Region: Global | 141 pages
The Worldwide Pharmaceutical Grade Lactose Market is projected to register a staggering CAGR of 4.76% to reach a revenue of USD 278.604 Million from the year 2019 to 2025. Pharmaceutical grade lactose has been applied as an excipient for quite some time now, probably more than a century. But due to its versatility, Pharmaceutical Grade Lactose is the backbone of plenty of successful formulations. Pharmaceutical Grade Lactose is made by easy concentrating whey or permeate (a definite co-product of advanced whey protein concentrates production) to over-saturate the formulae of lactose, then completely removing, purely refining, totally drying, and milling the lactose crystal particles. Pharmaceutical grade lactose is manufactured to cater to rigid specifications, for example, particular form and size distribution, commonly used monohydrate, crystalline, number of 40 mesh to 325 mesh, and plenty of spray-dried mixture of crystalline and various amorphous lactose for all different applications.
Plenty of factors that accelerate the market expansion are the rising demand for plenty of dry powder inhalers (DPI) products, various compatibility with active ingredients and other excipients, and various drug formulations, which is usually coupled with modern nanotechnology boosting the expansion of the various pharmaceutical grade lactose market. Not only this, stringent and very strict government regulations and total lack of compatibility with various amine-based drugs are hindering the pharmaceutical grade lactose market growth.
The Pharmaceutical grade lactose industry is projected to have a healthy expansion during the estimated period. The continuous growing use of this modern Pharmaceutical Grade Lactose as an enhanced solution is contributing to the growth of the demand for Pharmaceutical Grade Lactose globally. Uninterrupted introduction of technically sound and advanced products with augmented efficiency is also aiding the global market growth.
There has been a constantly increasing demand for modern technology, which expands the major demand for Pharmaceutical grade lactose size; there are plenty of advantages over traditional ones, and rising demand for the Pharmaceutical grade lactose Market, also because lack of proper infrastructure are few of the primary drivers for the pharmaceutical grade lactose market size. The large part of Europe is estimated to be the quickest growing area.
COVID 19 Impacts and effects
The COVID 19 has affected 215 countries and pharmaceutical-grade lactose manufacturers as well. To combat the negative effects, countries lead lockdowns that have adversely affected the pharmaceutical grade lactose market. The pandemic leads to several challenges to the sector; it is affected all over the world. Plenty of factors like the risk of uninterrupted production, supply chain, distribution, lack of workforce employees, and much-decreased development activities have primarily affected the ongoing demand and supply. People are not as active as earlier. Major strategic developments are taking place. MNC are investing more in the pharmaceutical grade lactose market of the increasing demand from consumers across the globe.
The increasing requirements for modern-day dry powder inhaler (DPI) products are driving market expansion. A dry powder inhaler (DPI) is basically created and formulated as a basic powder mixture of several coarse carrier particles, which is a micronized drug. These particular carrier particles are enhanced to improve drug particle flowability criteria; due to this, it continuously improves dosing accuracy, lessening the dose variability, which is compared with drug alone. As per the National Center for Biotechnology Information, pharmaceutical-grade lactose is the most widely and commonly used carrier in major DPIs formulations, and various α-lactose monohydrate is the probably the most common lactose grade used in the different types of inhalation.
There are four major regions across the globe that are majorly involved in the global pharmaceutical grade lactose market report – North America, Europe, Asia Pacific region, and Rest-of-the-World (RoW), depending upon the country-level market sizing. The pharmaceutical grade lactose market trends are very comprehensive; you have to understand each and every player in the market. There is no debate that in spite of the occurrences of COVID 19, the latest trends and future opportunities of the pharmaceutical grade lactose market growth will see tremendous spreading opportunities.
The increasing dependence on the pharmaceutical grade lactose market supports several industries around the globe that have doubled. The Pharmaceutical grade lactose market has come up as quite compelling easy solutions. The pharmaceutical grade lactose market has been very wide. There are lots of emerging markets related to pharmaceutical grade lactose all across the world, like India, China, and Brazil, that are projected to grow fast over the estimated years.
The outbreak of COVID-19 has hard severely knocked out the growing pace of the pharmaceutical grade lactose market growth. Because of mandatory closures of consumer markets and general healthcare across the globe, the profit share of the companies has been shrinking. COVID19 has disrupted the entire supply chain. A prolonged lockdown had a negative influence and affected the morale of the big pharma companies.
The pharmaceutical grade lactose market is projected to touch the earnings of an all-time high in 2023, according to an in-depth detailed report by the latest Market Research Future (MRFR). Around a CAGR of 4.1% is projected during the assessment period (2023) because of the impressive demand. Lots of factors are boosting the concept. The companies are planning and executing current business operations through innovative techniques. Many factors affect the growth of the pharmaceutical grade lactose, such as market size, trends in global technology, capital investment, etc.
In case of the pharmaceutical grade, lactose, as per the report, claims to have a 4.1% of CAGR by 2023 and a revenue of USD 229.48 MN by the end of year 2023. The demand and craze for it is rising, which has increased pharmaceutical grade lactose market growth. It is also estimated to increase at the most elevated speed over the given figure time frame, which is spreading or expanding across different industry verticals. Additionally, government support and customer interest are helping the market to expand. The development is primarily credited to little and medium undertakings or companies where fewer effort arrangements are significantly required.
The worldwide pharmaceutical grade lactose market is projected to witness great substantial growth during the estimated time period because of factors, for example, increasing demand for industrialization, huge investment in oil infrastructure, development in various and large scale industries along with the huge rapid expansion is also acting as another primary growth-inducing factor.
By Division by Structure
The Worldwide Pharmaceutical Grade Lactose Market has been divided on the basis of Type, and Application. The pharmaceutical grade lactose market, based on the basis of type, crystalline monohydrate lactose, inhalation lactose, tiny granulated lactose, spray-dried lactose, and others. The category of Crystalline Monohydrate Lactose is further subdivided into α-Lactose monohydrate and β-Lactose (anhydrous lactose). The concept of Inhalation Lactose is further subdivided into Sieved and Milled. The worldwide pharmaceutical grade lactose market, by primary application, has been subcategorized as various tablets manufacturing, different capsule manufacturing, and others. The section of Tablets manufacturing is further divided into direct compression, various wet granulation, and dry granulation. Different Capsule manufacturing is further subcategorized into capsules, sachets, and others.
On the basis of Geographic Segmentation:
Division by Application
The primary stakeholders in the pharmaceutical grade lactose market are research organizations, Traders, Importers, and Exporters, Suppliers, Industry end users. The concept is gaining momentum. The enterprises are focusing more intensely on improving product innovation techniques.
Division by Region
The regional analysis of several pharmaceutical grade lactose markets is being divided and studied, such as Asia Pacific, North America, European nations, and rest of the world countries. As per Geographical, North America is projected to be the biggest market in terms of profit contribution due to increased adoption of several cloud-based services by way of production systems and by several distribution channels. In addition to this, the countries of Asia Pacific are projected to grow rapidly in pharmaceutical grade lactose market due to increasing investment. Also, there has been a rise in demand in major developing countries; for example, India and China are projected to lead growth in several pharmaceutical grade lactose market in different Asia-Pacific regions.
There is no doubt; North America is leading the pharmaceutical grade lactose market due to the presence of the grand global players in this particular region as well as increased technological advancement.
Asia-Pacific Pharmaceutical Grade Lactose Market Share, by Country, 2019 (%)
Source: MRFR Analysis
|Market Size||278.604 Million (2025)|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Application, Capsule Manufacturing|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Kerry Inc. (Ireland), DFE Pharma (Germany), Meggle Excipients & Technology (Germany), Merck KGaA (Germany), Armor Pharma (France), ALPAVIT (Germany), BASF SE (Germany)|
|Key Market Opportunities||New product launches and R&D Amongst major key Players|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
Pharmaceutical grade lactose market projected to grow at approximately 4.1% CAGR during the assessment period (2020-2027).
The valuation of the global pharmaceutical grade lactose market is estimated to increase to USD 229.48 MN by the end of 2023.
The expanding pharmaceutical industry across the world and the proliferation of nanotechnology in drug production are major tailwinds pushing the growth of the global pharmaceutical grade lactose market.
Europe holds the largest share in the global pharmaceutical grade lactose market, followed by the Asia Pacific and North America, respectively.
Merck KGaA (Germany), Kerry Inc. (Ireland), BASF SE (Germany), Meggle (Germany), DFE Pharma (Germany), ALPAVIT (Germany), and Armor Pharma (France), are some of the top players operating in the global pharmaceutical grade lactose market.